Verastem
VSTM • NASDAQ
Verastem is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Daniel W. Paterson, with a market cap of $531.4M.
Market Cap$531.4M
Employees73.0
CEODaniel W. Paterson
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · In 2 weeksAfter Market Close · Q1 2026
Financials
Verastem FAQ
Common questions about Verastem
Verastem is scheduled to report earnings for Q1 2026 on May 12, 2026 after market close. Analysts estimate revenue of $21.8M.
Verastem has approximately 73 employees.